摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,2',3,3',4,4'-联苯六醇 | 4274-29-7

中文名称
2,2',3,3',4,4'-联苯六醇
中文别名
2(3H)-呋喃酮,5-丁基二氢-4-甲基-,(4S,5R)-
英文名称
2,2',3,3',4,4'-Hexahydroxy-biphenyl
英文别名
2,2',3,3',4,4'-Biphenylhexol;4-(2,3,4-trihydroxyphenyl)benzene-1,2,3-triol
2,2',3,3',4,4'-联苯六醇化学式
CAS
4274-29-7
化学式
C12H10O6
mdl
——
分子量
250.208
InChiKey
QPINXWKZYKLBNB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    310-320 °C (decomp)
  • 沸点:
    531.3±50.0 °C(Predicted)
  • 密度:
    1.721±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    18
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    121
  • 氢给体数:
    6
  • 氢受体数:
    6

安全信息

  • 海关编码:
    2906299090

SDS

SDS:04c3f436bde880f5c9b4672cc23ddca6
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Graebe; Suter, Justus Liebigs Annalen der Chemie, 1905, vol. 340, p. 230
    摘要:
    DOI:
  • 作为产物:
    描述:
    鞣花酸氢氧化钾 作用下, 以 为溶剂, 反应 0.22h, 生成 2,2',3,3',4,4'-联苯六醇
    参考文献:
    名称:
    3,4,8,9,10-Pentahydroxy-dibenzo[b,d]pyran-6-one 来自 Tamarix nilotica
    摘要:
    摘要 从柽柳花中分离得到一种新的天然产物 3,4,8,9,10-pentahydroxy-dibenzo-[b,d]pyran-6-one,其中还含有已知化合物鞣花酸、2,3 ,7,8-四羟基 [1]benzopyrano[5,4,3-cde][1]benzopyran-5,10-dione。新化合物的结构是通过化学和光谱方法确定的。记录并分配鞣花酸的 13C MNR 谱。
    DOI:
    10.1016/0031-9422(84)83057-5
点击查看最新优质反应信息

文献信息

  • Ellagic Acid and Its Metabolites as Potent and Selective Allosteric Inhibitors of Liver Pyruvate Kinase
    作者:Umberto Maria Battisti、Chunixa Gao、Fady Akladios、Woonghee Kim、Hong Yang、Cemil Bayram、Ismail Bolat、Metin Kiliclioglu、Nursena Yuksel、Ozlem Ozdemir Tozlu、Cheng Zhang、Jihad Sebhaoui、Shazia Iqbal、Saeed Shoaie、Ahmet Hacimuftuoglu、Serkan Yildirim、Hasan Turkez、Mathias Uhlen、Jan Boren、Adil Mardinoglu、Morten Grøtli
    DOI:10.3390/nu15030577
    日期:——

    Liver pyruvate kinase (PKL) has recently emerged as a new target for non-alcoholic fatty liver disease (NAFLD), and inhibitors of this enzyme could represent a new therapeutic option. However, this breakthrough is complicated by selectivity issues since pyruvate kinase exists in four different isoforms. In this work, we report that ellagic acid (EA) and its derivatives, present in numerous fruits and vegetables, can inhibit PKL potently and selectively. Several polyphenolic analogues of EA were synthesized and tested to identify the chemical features responsible for the desired activity. Molecular modelling studies suggested that this inhibition is related to the stabilization of the PKL inactive state. This unique inhibition mechanism could potentially herald the development of new therapeutics for NAFLD.

    丙酮酸激酶(PKL)最近已成为治疗非酒精性脂肪肝(NAFLD)的新靶点,这种酶的抑制剂可能是一种新的治疗选择。然而,由于丙酮酸激酶存在四种不同的同工酶,这一突破因选择性问题而变得复杂。在这项工作中,我们报告了存在于多种果和蔬菜中的鞣花酸(EA)及其衍生物可以有效地、选择性地抑制 PKL。我们合成并测试了几种鞣花酸的多酚类似物,以确定产生所需活性的化学特征。分子模型研究表明,这种抑制作用与 PKL 非活性状态的稳定有关。这种独特的抑制机制可能预示着非酒精性脂肪肝新疗法的开发。
  • Light-sensitive compositions
    申请人:FUJI PHOTO FILM CO., LTD.
    公开号:EP0410760A2
    公开(公告)日:1991-01-30
    A light-sensitive composition comprising: (a) a polysiloxane compound having at least 1 mol% of a structural unit derived from a product of a thermal cycloaddition reaction between a compound of formula (I), (II), (III) or (IV) and a compound of formula (V), (VI), (VII) or (VIII), and (b) an orthoquinonediazide compound.
    一种光敏组合物,包括 (a) 聚硅氧烷化合物,其结构单元至少有 1 摩尔%来自式(I)、(II)、(III)或 (IV)化合物与式(V)、(VI)、(VII)或(VIII)化合物之间的热环化反应产物, 以及 (b) 邻醌噻嗪化合物。
  • Process for synthesizing quinonediazide ester and positive working photoresist containing the same
    申请人:FUJI PHOTO FILM CO., LTD.
    公开号:EP0706089A2
    公开(公告)日:1996-04-10
    A process for synthesizing a quinonediazide ester is disclosed in which the esterification reaction of a polyhydroxy compound with 1,2-naphthoquinonediazide-5-(and/or -4-)sulfonyl chloride is carried out in the presence of a base catalyst comprising a basic compound represented by formula (I) or (II): wherein R₁ to R₁₅ are defined in the disclosure. A positive working photoresist containing the ester is also disclosed. The process is capable of highly selectively yielding the desired photosensitive material containing specific unreacted hydroxyl group(s). The photoresist has high resolving power with reduced film thickness dependence of the resolving power, is less apt to leave a development residue, and has excellent storage stability for prolonged period of time.
    本发明公开了一种合成喹酮噻嗪酯的工艺,在该工艺中,多羟基化合物与 1,2-萘醌噻嗪-5-(和/或-4-)磺酰氯的酯化反应是在碱催化剂存在下进行的,碱催化剂包括由式 (I) 或 (II) 所代表的碱化合物: 其中 R₁至 R₁₅的定义见公开内容。此外,还公开了一种含有该酯的正工作光刻胶。该工艺能够高选择性地得到所需的光敏材料,其中含有特定的未反应羟基。这种光刻胶具有很高的分辨力,同时降低了膜厚度对分辨力的依赖性,不易留下显影残留物,并且在长时间储存时具有极佳的稳定性。
  • Method of synthesizing polyphenol compound and positive working photoresist composition comprising polyphenol compound
    申请人:FUJI PHOTO FILM CO., LTD.
    公开号:EP0745575A1
    公开(公告)日:1996-12-04
    Provided are a method of synthesizing a highly pure polyphenol compound, which comprises (i) introducing at least one -CHRNR'R'' group onto aromatic ring(s) of a phenol compound having from one to ten aromatic ring(s), wherein R represents a hydrogen atom, an alkyl group which may contain a hetero atom, a cycloalkyl group which may contain a hetero atom, an aralkyl group which may contain a hetero atom, or an aryl group, and R' and R'', which may be the same or different, each represents an alkyl group which may contain a hetero atom, a cycloalkyl group which may contain a hetero atom, an aralkyl group which may contain a hetero atom, or an aryl group, and R' and R'' may combine with each other to form a ring, (ii) converting the -CHRNR'R'' group into a -CHRA group via one to three steps, wherein A represents a hydroxyl group, an alkoxy group, an acyloxy group, a halogen atom, a quaternary ammonium salt or a sulfonyloxy group, and (iii) condensing the thus converted phenol compound and a phenol compound, and a positive working photoresist composition using the polyphenol compound obtained by the aforementioned method.
    本发明提供了一种合成高纯度多化合物的方法,该方法包括(i)在具有一至十个芳香环的苯酚化合物的芳香环上引入至少一个-CHRNR'R''基团,其中 R 代表氢原子、可含有杂原子的烷基、可含有杂原子的环烷基、可含有杂原子的芳烷基或芳基、可含有杂原子的环烷基、可含有杂原子的芳烷基或芳基,R'和 R''可以相同或不同,各自代表可含有杂原子的烷基、可含有杂原子的环烷基、可含有杂原子的芳烷基、可含有杂原子的芳烷基、可含有杂原子的芳烷基、可含有杂原子的芳烷基、可含有杂原子的芳烷基、可含有杂原子的芳烷基、可含有杂原子的芳烷基、可含有杂原子的芳烷基、(ii) 通过一至三个步骤将 -CHRNR'R'' 基团转化为 -CHRA 基团,其中 A 代表羟基、烷氧基、酰氧基、环烷基或芳基、烷氧基、酰氧基、卤素原子、季盐或磺酰氧基,以及 (iii) 将由此转化的苯酚化合物和苯酚化合物缩合,并使用通过上述方法获得的多化合物制备正性工作光刻胶组合物。
  • Compositions for sleeping disorders
    申请人:Chan Chang Hsiao
    公开号:US20050261167A1
    公开(公告)日:2005-11-24
    Provided herein is a composition that contains an effective amount of one or more compounds for treating, preventing, or ameliorating a disorder such as insomnia or another sleeping disorder and using the composition.
    本文提供了一种组合物,其中含有有效量的一种或多种化合物,用于治疗、预防或改善失眠或其他睡眠障碍等疾病,以及使用该组合物。
查看更多